Reinikainen K

References (3)

Title : The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease - Alhainen_1993_J.Neural.Transm.Park.Dis.Dement.Sect_5_185
Author(s) : Alhainen K , Helkala EL , Reinikainen K , Riekkinen P, Sr.
Ref : J Neural Transm Park Dis Dement Sect , 5 :185 , 1993
Abstract :
PubMedSearch : Alhainen_1993_J.Neural.Transm.Park.Dis.Dement.Sect_5_185
PubMedID: 7690228

Title : Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease - Alhainen_1991_Neurosci.Lett_127_113
Author(s) : Alhainen K , Partanen J , Reinikainen K , Laulumaa V , Soininen H , Airaksinen M , Riekkinen P
Ref : Neuroscience Letters , 127 :113 , 1991
Abstract :
PubMedSearch : Alhainen_1991_Neurosci.Lett_127_113
PubMedID: 1881606

Title : Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine - Alhainen_1991_Neurosci.Lett_130_46
Author(s) : Alhainen K , Sirvio J , Helkala EL , Reinikainen K , Riekkinen P, Sr.
Ref : Neuroscience Letters , 130 :46 , 1991
Abstract :
PubMedSearch : Alhainen_1991_Neurosci.Lett_130_46
PubMedID: 1684233